Biotech
LAVAL, QUEBEC: - Favorable financing terms: -- No required repayment of either capital or interest during the 5-year term -- Confirms Thomvest's vision and support for value creation in ProMetic - The loan enab ...
SAN ANTONIO, TEXAS: Studio Scheduled for Completion Phase with November National Televison on Air Date
...
TORONTO, ONTARIO: NSERC IRDF grant to be used to study the use of Soricidin in Protecting Salmon industry from Sea Lice
...
CAVE CREEK, AZ: M3Hub Only Supports Companies in Compliance With the Law
...
TUSTIN, CA: Published Data Shows PS-Targeting Antibodies Such as Bavituximab Activate Tumor-Specific Immune Responses by Blocking PS-Mediated Immunosuppression; PS-Targeting Antibody Therapy Results in Adaptive I ...
HALIFAX, NOVA SCOTIA: Data demonstrates 100% protection against a lethal anthrax challenge after a single vaccination Animals produced sustained protective antibodies within 28 days following vaccination with the lowest an ...
WINNIPEG, MANITOBA: Summary of Eleven Key Studies using PreVu(R) POC Test to be Published in the Canadian Journal of Cardiology
...
LAVAL, QUEBEC: - PBI-4050 compares favorably to Pirfenidone, the only approved drug for IPF - PBI-4050 combined with Pirfenidone further reduces fibrosis in lungs - Data provides for regulatory pathway to address ...
